XML 53 R33.htm IDEA: XBRL DOCUMENT v3.21.2
Related party transactions
12 Months Ended
Mar. 31, 2021
Related Party Transactions [Abstract]  
Related party transactions
 
27.
Related party transactions
The table below sets forth the major related parties and their relationships with the Company as of March 31, 2019, 2020 and 2021:
 
Name of related parties
  
Relationship with the Company
Nanjing Xingmu  An equity investee of the Company before November 1, 2019
Nanjing Animal Pharmaceutical  An equity investee of the Company
Shanghai Yichong  An equity investee of the Company
Wuhan Chunzhijin  An equity investee of the Company
Beijing Petdog  An
available-for-sale
debt investee that the Company has significant influence
Yingzhi (Lisa) Tang  A senior management of the Company
Di (Jackie) Chen  A senior management of the Company
Ying (Christina) Zhang  A senior management of the Company
Fei Wang  A senior management of the Company
Yan Jiang  A senior management of the Company
Details of related party transactions and balances as of March 31, 2020 and 2021 are as follows:
The Company believes that the terms of the agreements with the related parties are comparable to the terms in
arm’s-length
transactions with third party customers and suppliers.
Transactions with related parties
 
   
Year Ended

March 31, 2019
   
Year Ended

March 31, 2020
   
Year Ended

March 31, 2021
 
   
RMB
   
RMB
   
RMB
 
Sales of goods
      
Beijing Petdog
   —      2,316    —   
  
 
 
   
 
 
   
 
 
 
 
   
Year Ended

March 31, 2019
   
Year Ended

March 31, 2020
   
Year Ended

March 31, 2021
 
   
RMB
   
RMB
   
RMB
 
Online marketing and information services
      
Beijing Petdog
   —      315    410 
  
 
 
   
 
 
   
 
 
 
   
Year Ended

March 31, 2019
   
Year Ended

March 31, 2020
   
Year Ended

March 31, 2021
 
   
RMB
   
RMB
   
RMB
 
Purchase of merchandise
      
Nanjing Xingmu
   2,533    751    —   
Nanjing Animal Pharmaceutical
   —      45    250 
  
 
 
   
 
 
   
 
 
 
   2,533    796    250 
  
 
 
   
 
 
   
 
 
 
   
Year Ended

March 31, 2019
   
Year Ended

March 31, 2020
   
Year Ended

March 31, 2021
 
   
RMB
   
RMB
   
RMB
 
Loans granted to related parties
      
Nanjing Animal Pharmaceutical (a)
   —      1,000    500 
Wuhan Chunzhijin (b)
   —      —      5,690 
Yan Jiang
   17,848    —      200 
Ying (Christina) Zhang
   —      152    —   
Di (Jackie) Chen
   —      785    —   
Fei Wang (c)
   —      —      500 
  
 
 
   
 
 
   
 
 
 
   17,848    1,937    6,890 
  
 
 
   
 
 
   
 
 
 
In December 2019, Nanjing Xingmu entered into a twelve-month interest free loan agreement with Nanjing Agricultural Pharmaceutical for a principal amount of RMB1 million. This loan was early repaid in May 2020. In June 2020, Nanjing Xingmu entered into another twelve-month interest free loan agreement with Nanjing Agricultural Pharmaceutical for a principal amount of RMB0.5 million. As of March 31, 2021, the outstanding principal amount under this agreement was RMB0.5 million.
 
 (a)
From April 2020 to January 2021, the Company entered into several interest free loans with Wuhan Chunzhijin for a total principal of RMB5.7 million.
 
 (b)
In January 2021, the Company entered into a one-year loan agreement with Fei Wang, for a principal amount of RMB0.5 million, bearing an interest rate of 4% per annum. This Loan was pledged by 515,000 stock options owned by Fei Wang.
 
   
Year Ended

March 31, 2019
   
Year Ended

March 31, 2020
   
Year Ended

March 31, 2021
 
   
RMB
   
RMB
   
RMB
 
Staff advances
      
Yingzhi (Lisa) Tang
   —      —      10 
Di (Jackie) Chen
   528    6    —   
  
 
 
   
 
 
   
 
 
 
   528    6    10 
  
 
 
   
 
 
   
 
 
 
Advances provided to related parties
      
Nanjing Animal Pharmaceutical
   —      —      2,073 
Wuhan Chunzhijin
   2,720    3,350    —   
  
 
 
   
 
 
   
 
 
 
   2,720    3,350    2,073 
  
 
 
   
 
 
   
 
 
 
Loans granted from related parties
      
Yingzhi (Lisa) Tang (a)
   5,014    1,450    —   
Di (Jackie) Chen (b)
   —      1,250    —   
Yan Jiang (c)
   —      9,000    —   
  
 
 
   
 
 
   
 
 
 
   5,014    11,700    —   
  
 
 
   
 
 
   
 
 
 
(a) In September 2019, the Company obtained a
two-year
loan of RMB1.5 million from Yingzhi (Lisa) Tang, bearing an interest rate of 9.0% per annum. The loan was early repaid in December 2020.
In November 2018, Yingzhi (Lisa) Tang advanced RMB4 million to the Company, which was repaid by the Company in the same month.
In July 2018, the Company obtained a forty-month loan of US$0.15 million (RMB1 million) from Yingzhi (Lisa) Tang, bearing an interest rate of 6.0% per annum. The loan was early repaid in January 2021.
(b) In October 2019, Di (Jackie) Chen advanced RMB1.25 million to the Company, which was repaid by the Company in the same month.
(c) In September 2019, the Company obtained a
two-year
loan of RMB9 million from Yan Jiang, bearing an interest rate of 9.0% per annum. The loan was early repaid in December 2020.
Amounts due from related parties
 
   
As of March 31,
2019
   
As of March 31,
2020
   
As of March 31,
2021
 
   
RMB
   
RMB
   
RMB
 
Trade receivables from related parties
      
Beijing Petdog
   —      1,564    —   
  
 
 
   
 
 
   
 
 
 
Prepayments to related parties
      
Nanjing Animal Pharmaceutical
   —      —      2,023 
Nanjing Xingmu
   138    —      —   
  
 
 
   
 
 
   
 
 
 
   138    —      2,023 
  
 
 
   
 
 
   
 
 
 
 
   
As of March 31,
2019
   
As of March 31,
2020
   
As of March 31,
2021
 
   
RMB
   
RMB
   
RMB
 
Other receivables from related parties
      
Wuhan Chunzhijin
   3,795    2,481    7,295 
  
 
 
   
 
 
   
 
 
 
Loans to related parties
      
Nanjing Animal Pharmaceutical
   —      1,000    500 
Yingzhi (Lisa) Tang
   —      —      10 
Yan Jiang
   —      —      200 
Di (Jackie) Chen (a)
   —      785    785 
Ying (Christina) Zhang
   —      152    152 
Fei Wang (b)
   —      —      500 
  
 
 
   
 
 
   
 
 
 
   —      1,937    2,147 
  
 
 
   
 
 
   
 
 
 
 
 (a)
In December 2019, the Company entered into a twelve-month interest free loan agreement with, Di (Jackie) Chen, for a principal amount of RMB0.7 million. In December 2020, the loan contract was renewed for another one year.
 
 (b)
In January 2021, the Company entered into a one-year loan agreement with Fei Wang, for a principal amount of RMB0.5 million, bearing an interest rate of 4% per annum. This Loan was pledged by 515,000 stock options owned by Fei Wang.
Amounts due to related parties
 
   
As of March 31,
2019
   
As of March 31,
2020
   
As of March 31,
2021
 
   
RMB
   
RMB
   
RMB
 
Trade payables to related parties
      
Nanjing Animal Pharmaceutical
   —      45    874 
  
 
 
   
 
 
   
 
 
 
   
As of March 31,
2019
   
As of March 31,
2020
   
As of March 31,
2021
 
   
RMB
   
RMB
   
RMB
 
Advances from related parties
      
Beijing Petdog
   —      —      36 
Wuhan Chunzhijin
   150    —      —   
  
 
 
   
 
 
   
 
 
 
   150    —      36 
  
 
 
   
 
 
   
 
 
 
Long-term loan from related parties
      
Yingzhi (Lisa) Tang (a)
   1,015    2,521    —   
Yan Jiang (b)
   —      9,000    —   
  
 
 
   
 
 
   
 
 
 
   1,015    11,521    —   
  
 
 
   
 
 
   
 
 
 
 
 (a)
In July 2018, the Company entered into a forty-month loan agreement with Yingzhi (Lisa) Tang, for a principal amount of US$0.15 million (RMB1.0 million), bearing an interest rate of 6% per annum. The loan was early repaid in January 2021.
In September 2019, the Company entered into another
two-year
loan agreement with Yingzhi (Lisa) Tang, for the principal amounts of RMB1.5 million, bearing an interest rate of 9% per annum. The loan was early repaid in December 2020.
 
 (b)
The balance as of December 31, 2019 represented a
two-year
loan of RMB9 million due to Yan Jiang, bearing an interest rate of 9.0% per annum. The loan was early repaid in December 2020.